Dette kunne muligvis føre til forhøjede plasmaniveauer af lægemidler som phenytoin og tolbutamid samt de NSAID’ er, som metaboliseres af cytochrom P450 2C9.
This could potentially lead to increased plasma levels of medicinal products such as phenytoin and tolbutamide and the NSAIDs, which are metabolised by Cytochrome P450 2C9.